Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.

Zhu Z, Sun Z, Wang Z, Guo P, Zheng X, Xu H.

J Surg Res. 2013 Jul;183(1):177-83. doi: 10.1016/j.jss.2013.01.023. Epub 2013 Feb 4.

PMID:
23462454
2.

Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.

Hou T, Liang D, Xu L, Huang X, Huang Y, Zhang Y.

Gynecol Oncol. 2013 Jul;130(1):181-7. doi: 10.1016/j.ygyno.2013.04.015. Epub 2013 Apr 17.

3.

Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.

Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2011 Feb;125(3):715-27. doi: 10.1007/s10549-010-0875-2. Epub 2010 Apr 6.

PMID:
20369284
4.

The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.

Lee JH, Cho YS, Lee JY, Kook MC, Park JW, Nam BH, Bae JM.

Ann Surg. 2009 Jun;249(6):933-41. doi: 10.1097/SLA.0b013e3181a77ccc.

PMID:
19474687
5.

Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.

Xing YN, Xu XY, Nie XC, Yang X, Yu M, Xu HM, Liu YP, Takano Y, Zheng HC.

Hum Pathol. 2012 Dec;43(12):2299-307. doi: 10.1016/j.humpath.2011.08.027. Epub 2012 Aug 3.

PMID:
22863086
6.

Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.

Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM.

Med Oncol. 2014 Sep;31(9):145. doi: 10.1007/s12032-014-0145-y. Epub 2014 Aug 6.

PMID:
25097078
7.

An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.

Allgayer H, Babic R, Grützner KU, Beyer BC, Tarabichi A, Wilhelm Schildberg F, Heiss MM.

Cancer. 1997 Jul 15;80(2):179-87.

PMID:
9217027
8.

Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.

Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM.

Clin Cancer Res. 2009 May 1;15(9):2962-70. doi: 10.1158/1078-0432.CCR-08-2495. Epub 2009 Apr 21.

9.

Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma.

He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, Wang Z, Li W, Chen W, Chen CY, He YL, Zhan WH.

Eur J Surg Oncol. 2013 Feb;39(2):141-9. doi: 10.1016/j.ejso.2012.08.023. Epub 2012 Sep 19.

PMID:
22999412
10.

[Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].

Su XJ, Tang ZF, Li Q, Li HL, Li LL, Liu M, Zhou YN.

Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):276-9. Chinese.

PMID:
21575498
11.

Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.

Yu KD, Wang X, Yang C, Zeng XH, Shao ZM.

Oncotarget. 2015 Sep 22;6(28):26519-27. doi: 10.18632/oncotarget.4470.

12.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473. Epub 2011 Sep 22.

PMID:
21947329
13.

Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Luo D, Huang H, Lu ML, Zhao GF, Chang J, Zheng MY, Wang Y.

Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x. Epub 2011 Nov 23.

PMID:
22109561
14.

Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma.

Sha S, Gu Y, Xu B, Hu H, Yang Y, Kong X, Wu K.

Dig Liver Dis. 2013 May;45(5):422-9. doi: 10.1016/j.dld.2012.12.004. Epub 2013 Jan 14.

PMID:
23332081
15.

Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.

Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y.

Hum Pathol. 2008 Jul;39(7):1042-9. doi: 10.1016/j.humpath.2007.11.009. Epub 2008 May 14.

PMID:
18482745
16.

Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas.

Zheng HC, Xu XY, Xia P, Yu M, Takahashi H, Takano Y.

Hum Pathol. 2010 Sep;41(9):1255-64. doi: 10.1016/j.humpath.2010.02.003. Epub 2010 May 5.

PMID:
20447678
17.

Expression profile and prognostic role of sex hormone receptors in gastric cancer.

Gan L, He J, Zhang X, Zhang YJ, Yu GZ, Chen Y, Pan J, Wang JJ, Wang X.

BMC Cancer. 2012 Dec 2;12:566. doi: 10.1186/1471-2407-12-566.

18.

Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.

Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S.

World J Surg. 2011 Sep;35(9):2051-7. doi: 10.1007/s00268-011-1186-4.

PMID:
21748517
19.

Downregulation of ABI1 expression affects the progression and prognosis of human gastric carcinoma.

Cui M, Yu W, Dong J, Chen J, Zhang X, Liu Y.

Med Oncol. 2010 Sep;27(3):632-9. doi: 10.1007/s12032-009-9260-6. Epub 2009 Jun 25.

PMID:
19554484
20.

Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.

Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, Hou M.

J Exp Clin Cancer Res. 2011 Jan 28;30:14. doi: 10.1186/1756-9966-30-14.

Supplemental Content

Support Center